#Japan #Tokyo #CDMO #Ajinomoto #Bio-Pharma Services

Ajinomoto Bio-Pharma Services Launches Renewed Global Brand

Ajinomoto Bio-Pharma Services, commonly known as Aji Bio-Pharma, has recently introduced a refreshed global brand identity aimed at highlighting its specialization in biopharmaceutical development and manufacturing. This initiative includes an updated visual identity, a revamped website, and a clear message outlining the company’s core focus and commitment to aiding clients in developing life-enhancing medicines.

With the growing need for biopharmaceutical companies to face increasingly complex challenges in development and manufacturing, Aji Bio-Pharma underscores its strength in specialization. The company's expertise spans a wide range of biopharmaceuticals, including small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates. By concentrating on these specific areas, Aji Bio-Pharma leverages scientific innovation to tackle the unique challenges of the biopharmaceutical sector.

The foundation of this specialization lies in over a century of scientific innovation within the Ajinomoto Group. This rich legacy continues to influence Aji Bio-Pharma, particularly through the development of proprietary technologies that advance the fields of biopharmaceutical development and manufacturing. By emphasizing quality, operational excellence, and sustainable practices, Aji Bio-Pharma ensures that it offers clients the reliability and partnership they depend on to advance their programs.

Yasuyuki Otake, an executive and general manager at Ajinomoto Co., Inc., stated, "Our team has always been committed to discovering innovative and efficient solutions to the specific challenges our clients face in development and manufacturing. Our new brand places this strength at the heart of its identity. It reflects the ingenuity of our teams worldwide and our dedication to helping our clients stimulate innovation and unleash the full potential of their scientific research for the benefit of the patients they serve."

The refreshed brand identity has been prominently launched across Aji Bio-Pharma's website, social media platforms, and updated marketing materials. This comprehensive update will also be showcased at upcoming conventions and events, with additional materials adopting the new branding in the coming months.

About Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services operates as a global network of organizations specialized in contract development and manufacturing (CDMO) and generic technologies. With expertise in diverse fields such as small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates, Aji Bio-Pharma combines in-depth knowledge with the Ajinomoto Group's century-long history of scientific innovation. With facilities in Belgium, India, Japan, and the United States, the company is committed to quality, operational excellence, and sustainability to support biopharmaceutical partners in advancing the development of complex and innovative medicines and contributing to better health outcomes globally. For more information, visit www.AjiBio-Pharma.com.

Media Contact

For press inquiries, click HERE.